Restart Life Sciences Corp. (CSE: HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.0350
0.00 (0.00%)
Jan 20, 2025, 9:30 AM EST
-65.00%
Market Cap 1.26M
Revenue (ttm) -28.35K
Net Income (ttm) 15.05K
Shares Out 36.02M
EPS (ttm) -0.00
PE Ratio 83.78
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,445
Average Volume 36,113
Open 0.0300
Previous Close 0.0350
Day's Range 0.0300 - 0.0350
52-Week Range 0.0150 - 0.1250
Beta 0.72
RSI 49.54
Earnings Date Apr 8, 2025

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.